Breaking News Instant updates and real-time market news.

2017-09-15 09:46:19

BCS

Barclays

$10.11

0.02 (0.20%)

09:46

09/15/17

09/15

09:46

09/15/17

09:46

Barclays' head of whistleblowing Jonathan Cox set to leave bank, FT reports

Jonathan Cox, a former police detective who has been Barclays' global head of whistleblowing for over two years, has withdrawn an employment tribunal case against the bank and is now planning to leave the bank, The Financial Times reports. According to a person familiar with the matter, Cox agreed to an out-of-court settlement with Barclays and is likely to leave the bank "soon." Reference Link

BCSBarclays

$10.11

0.02 (0.20%)

05/05/17

GSCO

05/05/17DOWNGRADEGSCOSell

Barclays downgraded to Sell from Neutral at Goldman Sachs

Goldman Sachs analyst Martin Leitgeb downgraded Barclays to Sell and lowered his price target for the shares to 180p from 250p.

05/17/17

UBSW

05/17/17UPGRADEUBSWBuy

Barclays upgraded to Buy from Neutral at UBS

UBS analyst Jason Napier upgraded Barclays to Buy from Neutral citing its relative underperformance and its discount valuation relative to its Net Asset Value. He also does not believe the bank is facing a near-term capital shortfall, which has been a source of investor concern. He lowered his price target on Barclays shares to 235p from 240p.

UP AFTER EARNINGS: Cintas (CTAS), up 2.9%... Micron (MU), up 2.8%. ALSO HIGHER: Editas Medicine (EDIT), up 3.1% after it received the EMA's orphan medicinal product designation for EDIT-101... Twitter (TWTR), up 1.8% after it said it will start testing longer, 280-character tweets with a small group. DOWN AFTER EARNINGS: Nike (NKE), down 3.2%. ALSO LOWER: Kornit Digital (KRNT), down 12.2% after it cut its third quarter revenue guidance... Westlake Chemical Partners (WLKP), down 8.3% after it filed to sell 4.5M units for limited partners... Intra-Cellular (ITCI), down 7.2% after it filed to sell $150M in common stock... Ascendis Pharma (ASND), down 4.3% after it announced an offering of $125M of ADSs.